Stony Brook, NY, United States of America

Advanced Immuni T, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

Forward Citations = 25

Loading Chart...

16 inventors (with patents filed for the assignee):

Deborah Ann Rathjen (2 out of 24 patents)

Roger Aston (2 out of 17 patents)

Fred Widmer (2 out of 7 patents)

4. David James Phipps (2 out of 3 patents)

5. Douglas Kevin MacFadden (2 out of 3 patents)

6. Penelope Reed Doob (2 out of 3 patents)

7. Peter Louis Carlen (2 out of 3 patents)

8. Anders Jorgen Andersen (2 out of 4 patents)

9. Candace B Pert (2 out of 11 patents)

10. Michael R Ruff (2 out of 18 patents)

11. Michael A Davis (1 out of 9 patents)

12. Dennis A Casciato (1 out of 1 patent)

13. Jeffrey E Galpin (1 out of 1 patent)

14. Saul M Levin (1 out of 1 patent)

15. MerriBeth Adams (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6713445 - Peptides for treatment of HIV infection (2004-03-30),

2. 6265374 - Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis (2001-07-24),

3. 6011014 - Peptide T and related peptides in the treatment of inflammation, (2000-01-04),

4. 5739109 - Method of treating neuroinflammatory degenerative diseases (1998-04-14),

Company Overview

Advanced Immuni T, Inc. is a biotechnology company specializing in developing innovative immunotherapy treatments for various diseases. Their proprietary technology has shown promising results in enhancing the immune system's ability to fight off infections and diseases. With a focus on precision medicine, Advanced Immuni T is revolutionizing the field of immunotherapy and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

4 Patents

#8 in Stony Brook, NY

#3,688 in New York

#60,778 in US

Stony Brook, NY, United States of America